"10.1371_journal.pone.0008275","plos one","2009-12-14T00:00:00Z","Marie Ballif; Bruno Ledergerber; Manuel Battegay; Matthias Cavassini; Enos Bernasconi; Patrick Schmid; Bernard Hirschel; Hansjakob Furrer; Martin Rickenbach; Milos Opravil; Rainer Weber; the Swiss HIV Cohort Study Â¶","Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Division of Infectious Diseases and Hospital Epidemiology, University Hospital, Basel, Switzerland; Division of Infectious Diseases and Hospital Epidemiology, University Hospital, Lausanne, Switzerland; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital, Lugano, Switzerland; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital, St. Gallen, Switzerland; Division of Infectious Diseases and Hospital Epidemiology, University Hospital, Geneva, Switzerland; Division of Infectious Diseases, University Hospital Bern, and University of Bern, Bern, Switzerland; Swiss HIV Cohort Study, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland","Conceived and designed the experiments: MB BL MB MC EB PS BH HF MR MO RW. Analyzed the data: MB BL. Contributed reagents/materials/analysis tools: MB MC EB PS BH HF MR MO RW. Wrote the paper: MB BL MO RW. Critical revision of the manuscript and approval: MB MC EB PS BH HF MR MO.","M.Bal. has no conflicts of interest. B.L. has received travel grants, grants or honoraria from Abbott, Aventis, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Merck Sharp & Dohme, Roche and Tibotec. M.Bat. has received research grants or speakers' honoraria from Abbott, Bristol-Myers Squibb, Boehringer-Ingelheim, GlaxoSmithKline, Hoffmann-La Roche, Merck Sharp & Dohme, TRB Chemedica, and Tibotec; and serves as a consultant for Boehringer-Ingelheim (Switzerland) and Hoffmann-La Roche (Switzerland). M.C. has received travel grants from Abbott, Gilead, Roche, and Boehringer-Ingelheim. E.B. has received travel grants or honoraria from Gilead, Roche, GlaxoSmithKline, Pfizer, Boehringer-Ingelheim, and Tibotec. P.S. has received travel grants from Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Roche, Tibotec, Abbott, and Pfizer. B.H. has received travel grants and speakers' honoraria from Abbott, Bristol-Myers Squibb, Gilead, Glaxo, Merck, and Roche. H.F. has participated in advisory boards of GlaxoSmithKline, Bristol-Myers Squibb, Gilead, Merck Sharp & Dohme, Boehringer-Ingelheim; Janssen. M.R. received travel grants from GlaxoSmithKline. M.O. and R.W. have received travel grants or speakers honoraria from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck Sharp & Dome, Pfizer, LaRoche, TRB Chemedica and Tibotec.","2009","12","Marie Ballif","MB",12,TRUE,10,NA,2,4,TRUE,TRUE,TRUE,1,"12",TRUE
